
iRhythm Technologies (IRTC) Stock Forecast & Price Target
iRhythm Technologies (IRTC) Analyst Ratings
Bulls say
iRhythm Holdings is well-positioned in the digital healthcare market with its innovative technology and strategic acquisitions. The company has shown strong performance with raised revenue guidance and plans for further expansion through the acquisition of VitalConnect. With a positive outlook for continued growth, it is a promising investment in the increasingly important healthcare technology sector.
Bears say
iRhythm Holdings is performing well, with solid revenue and EBITDA beats in the second quarter and consistent revenue growth above 20% every quarter. Innovative channel partners are a key contributor to this growth, and the company expects continued success in this area. While the FDA warning letter may pose a challenge, management is confident in their remediation efforts and has a strong plan in place. Additionally, the company has identified opportunities for growth through their home sleep test pilot program, which leverages their existing customer base and addresses a fragmented market.
This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.
iRhythm Technologies (IRTC) Analyst Forecast & Price Prediction
Start investing in iRhythm Technologies (IRTC)
Order type
Buy in
Order amount
Est. shares
0 shares